MCET

MULTICELL TECHS INC by MultiCell Technologies, Inc. (MCET)

About MULTICELL TECHS INC by MultiCell Technologies, Inc. (MCET)

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Dallas, TX.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
5,000
Dividend yield
0.00%
Volume
100,000
Avg. volume
177,226
P/E ratio
--

MULTICELL TECHS INC by MultiCell Technologies, Inc. News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
5,000
Dividend yield
0.00%
Volume
100,000
Avg. volume
177,226
P/E ratio
--